4/11/2024NHSA Disputes Claims of a 'Dropout Wave' in China's Basic Medical Insu...

4/11/2024Out-of-Area Medical Bill Settlement Jumps Nearly Fourfold After BMI S...

4/11/2024Drugmakers Race to Find Alternative Suppliers as US Cracks Down on Chi...

4/11/2024Geopolitics Threatens Chinese Biotechs' Hot Out-licensing Biz (Fierce ...

4/10/2024Biosimilars Coming into Their Own in China, Despite Concerns (Bioworld...

4/10/2024Generic Drugs Has Experienced Falling Market Share Since 2018

4/9/2024Broad Measures Outlined at the 2024 Natl Conference on Rectifying Viol...

4/9/2024Chinese VMS OTC Market Growth Rebounds to 7.3% in 2023

4/8/2024Boehringer Ingelheim and Sino Biopharm Enter Strategic Deal to Develop...

4/8/2024Over 11M Chinese Residents Benefited from Major Disease Insurance in 2...

4/8/2024NMPA Announces OTC Switch of Bismuth Potassium Citrate Capsules

4/5/2024China Continues to Crackdown on Monopoly and Unfair Market Practices i...

4/5/2024Recent Official Changes and Executive Moves

4/5/2024Foreign Investors Fled Chinese Biotech After the Pandemic. They Still ...

4/4/2024Rohto and Mitsui to Buy TCM Company for $590M

4/3/2024Genmab A/S to Acquire ADC Developer ProfoundBio for $1.8B Cash

4/3/2024What To Know About Jiyoutai - China's First Potential Ozempic Challeng...

4/2/2024NHC Holds the 2024 National Drug Administration Work Conference

4/2/2024Aurisco Launches State-of-the-Art Manufacturing Facility for GLP-1 Pep...

4/1/2024CDE Solicits Comments on the Technical Guidelines for Clinical Trial D...

4/1/2024Congress Targets Biotech Suppliers for Pentagon Watchlist Amid China S...

4/1/2024CMS and Incyte Enter License Deal for Povorcitinib in China and SE Asi...

3/30/2024JPO Launches Follow-On Procurement for the National Level Insulin VBP ...

3/30/2024Recent Official Changes and Executive Moves

3/30/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...

3/29/2024WuXi AppTec Shared US Client's Data with Beijing (Reuters)

3/29/2024Small Biotechs Reveal Reliance on Chinese CDMOs (BioCentury)

3/29/2024NMPA Holds the 2024 National Drug Regulatory Policy and Regulation Wor...

3/27/2024U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (WSJ...

3/27/2024BIOSECURE Act May Implicate WuXi-Produced Drugs in the US Market

Page:41/367 Total number of articles:11001: [First][<<] [39] [40] [41] [42] [43] [>>] [End]